Congenital Disorder of Glycosylation-Ic: Case Report and Genetic Defect

The clinical phenotype and the molecular defect of a patient with a new subtype of congenital disorders of glycosylation (CDG-Ic, formerly designated as CDGS type V) characterized by a deficiency of Dol-P-Glc : Man₉GlcNAc₂-PP-Dol glucosyltransferase is described. The clinical picture presents with several features similar to CDG-Ia (phosphomannomutase 2 deficiency) such as hypotonia and atactic-dystonic movements. In contrast to CDG-Ia, the course of the disease appears milder. The head growth, the functioning of the peripheral nerves and the initial cerebellar development were normal. Sequencing of the patient's Dol-P-Glc : Man₉GlcNAc₂-PP-Dol glucosyltransferase cDNA revealed an in-frame deletion of three nucleotides leading to the loss of isoleucine 299.

Key words

CDG - Dol-P-Glc : Man₉ - GlcNAc₂ - -PP-Dol glucosyltransferase

References

• 1 Hagberg B, Blennow G, Kristiansson B, Stibler H. Carbohydrate-deficient glycoprotein syndromes: Peculiar groups of new disorders.  Pediatr Neurol. 1993;  9 255-262
• 2 Imbach T, Burda P, Kuhnert P, Wevers R A, Aebi M, Berger E G, Hennet T. A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-1 c.  Proc Natl Acad Sci USA. 1999;  96 6982-6987
• 3 Jaeken J, Vanderschueren-Lodeweyckx M, Casaer P, Snoeck L, Corbeel L, Eggermont E, Eeckels R. Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and Gh levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: A new syndrome.  Pediatr Res. 1980;  14 179
• 4 Jaeken J, Schachter H, Carchon H, De Lock P, Coddeville B, Spik G. Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase.  Arch Dis Child. 1994;  71 123-127
• 5 Körner C, Knauer R, Holzbach U, Hanefeld F, Lehle L, von Figura K. Carbohydrate deficient glycoprotein syndrome type V: Deficiency of dolichyl-P-Glc: Man₉GlcNAc₂-PP-dolichyl glucosyltransferase.  Proc Natl Acad Sci USA. 1998;  95 13 200-13 205
• 6 Körner C, Knauer R, Stephani U, Marquardt T, von Figura,  K. Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man5GlcNAc2-PP-dolichyl mannosyltransferase.  EMBO J. 1999;  18 6816-6822
• 7 Lübke T, Marquardt T, von Figura K, Körner C. A new type of carbohydrate deficient glycoprotein syndrome due to a decreased import of GDP-fucose into the Golgi.  J Biol Chem. 1999;  274 25 986-25 989
• 8 Matthijs G, Schollen E, Pardon E, Veiga-Da-Cuhna M, Jaeken J, Cassiman J-J, van Schaftingen E. Mutations in PMM2, a phosphomannomutase gene on chromosome 16 p13, in carbohydrate-deficient glycoprotein type I syndrome.  Nat Genet. 1997;  16 88-92
• 9 Niehus R, Hasilik M, Alton G, Körner C, Schiebe-Sukumar M, Koch H G. et al . Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.  J Clin Invest. 1998;  101 1414-1420
• 10 Stibler H, Westerber B, Hanefeld F, Hagberg B. Carbohydrate deficient glycoprotein (CDG) syndrome - a new variant type III.  Neuropediatrics. 1993;  24 51-52
• 11 Stibler H, Stephani U, Kutsch U. Carbohydrate-deficient glycoprotein syndrome - A fourth subtype.  Neuropediatrics. 1995;  26 235-237
• 12 van Schaftingen E, Jaeken J. Phosphomannomutase deficiency is a cause of carbohydrate deficient glycoprotein syndrome type I.  FEBS Lett. 1995;  377 318-320